HIT Consultant December 6, 2022
Rachael Scott, Chief Commercial Officer, Lightship

Making clinical trials equitable is one of the biggest challenges we face as an industry. We see this time and again, with one of the latest examples coming in the form of a study published in JAMA Network Open that found substantial underrepresentation of Black patients enrolled in pivotal trials for CAR-T therapy.  

Women are another demographic negatively affected by inequality in clinical research. Earlier this month [May 2022] the American Heart Association issued a presidential advisory warning that gaps in cardiovascular disease research are putting the lives of female patients at risk.  There are socio-economic disparities, too. For example, those with household incomes below $50,000 dollars per year are 27% less likely to participate in clinical trials.

We have,...

Today's Sponsors

Transcarent
SalesSparx

Today's Sponsor

Health Edge

 
Topics: Biotechnology, Clinical Trials, Pharma, Pharma / Biotech, Survey / Study, Trends
Three Wild Health Technologies in (or Close to) Clinical Trials
How the Cloud Can Improve Data Sets for Real-World Evidence in Clinical Trials
Health Equity Barriers in Oncology Trials
Nationwide Children's Hospital AI spinoff acquired by new $200M clinical trial startup
Clinical trial company Science 37 buys life science assets from Vault Health

Share This Article